ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Eve Wellness Empowers Women with Advanced AI Technology for Early Breast Screenings

By: PRLog

SAN FRANCISCO - June 20, 2023 - PRLog -- Eve Wellness, a leading healthcare provider in San Francisco, is transforming breast cancer detection by empowering women with state-of-the-art AI technology for early screenings. By integrating AI with Ultrasound screening with the output read by a leading breast surgeon, Eve Wellness aims to enhance the detection of breast cancer, particularly in women with dense breast tissue, which can pose challenges for traditional mammography.

San Francisco now boasts an innovative clinic that offers the combined benefits of FDA-approved Breast Ultrasound and FDA-approved AI. Extensive clinical trials have revealed that when used alongside the GE ABUS, the QView CAD AI Assistant can identify an impressive 35.7% more cancer than ABUS alone.

Eve Wellness is committed to providing women access to cutting-edge breast screening technology by integrating AI capabilities with the GE ABUS Ultrasound machine. This comprehensive ultrasound examination of the entire breast yields highly accurate results without exposing patients to radiation or discomfort. The clinic offers convenient same-day appointments without needing a doctor's referral, ensuring accessibility for all. Prompt physician-read results are delivered within 24 hours, offering women peace of mind.

"At Eve Wellness, our primary focus is empowering women to take proactive steps in managing their breast health and undergoing screenings at an early stage," emphasized Brendan Foley, Chief Marketing Officer at Eve Wellness. "The recent shift in screening age signifies a significant change in our fight against this disease. Lowering the screening age to 40 underscores the potential for more proactive measures, particularly for the substantial demographic of women with dense breast tissue. Ultrasound screening is a leading screening solution for women with dense breast tissue and deserves serious consideration for women wanting to be proactive about their health."

Medical Director Dr. Ian Grady, MD, a highly experienced breast surgeon specializing in breast cancer detection and treatment for over 35 years, leads the expert team at Eve Wellness. Dr. Grady's expertise and unwavering dedication ensure that patients at Eve Wellness receive the highest level of care and attention.

Recent guidelines from experts and an enlightening report by the Los Angeles Times highlighted the importance of early breast screenings with the latest technology. Women are advised not to wait until age 50 to undergo screening and are encouraged to consider the safety and effectiveness of breast ultrasounds. At Eve Wellness, women can begin screening as early as their 20s. As The New York Times emphasized, AI represents a significant advancement in detection, particularly when analyzing thousands of ultrasound images. The combination of GE ABUS and QVCad AI distinguishes Eve Wellness from other facilities in San Francisco.

Breast cancer remains one of the most prevalent forms of cancer among women in the United States, with over 43,000 annual deaths nationwide. Regular screenings are crucial for early detection and pivotal in successful treatment. Notably, nearly half of all women have dense breast tissue, which presents challenges in cancer detection with standard mammography.  However, through the use of breast ultrasound screenings, cancer can be detected much better in dense breast tissue..

For more information about Eve Wellness and its state-of-the-art breast screening services, please visit www.myevewellness.com.

Media Contact
Brendan Foley
CMO - Eve Wellness
info@myevewellness.com

Photos: (Click photo to enlarge)

Eve Wellness Logo

Read Full Story - Eve Wellness Empowers Women with Advanced AI Technology for Early Breast Screenings | More news from this source

Press release distribution by PRLog

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.